会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • 4'-Fluoro-4-{[4-(phenyl)cyclohexyl]amino}butyrophenones and the salts
thereof
    • 4 {40-氟-4- {55 {8 4-(苯基)环己基{9氨基{56丁基苯及其盐
    • US3960961A
    • 1976-06-01
    • US329044
    • 1973-02-02
    • Daniel Lednicer
    • Daniel Lednicer
    • C07C45/29C07C45/62C07C45/66C07C49/657C07C49/683C07C49/697C07C49/747C07D295/073C07C97/10
    • C07D295/073C07C247/00C07C45/292C07C45/62C07C45/66C07C49/657C07C49/683C07C49/697C07C49/747
    • This invention relates to novel 4-phenylcyclohexylamines embraced by the formula ##SPC1##Wherein .about. is a generic expression denoting cis and trans stereoconfiguration and mixtures thereof; R is selected from the group consisting of alkyl of from one through four carbon atoms, fluorine, chlorine, bromine, trifluoromethyl, nitro and alkoxy of from one through four carbon atoms; R' and R.sup.1 are selected from the group consisting of hydrogen and alkyl of from one through four carbon atoms; R.sup.2 is selected from the group consisting of hydrogen, alkyl of from one through four carbon atoms, alkanoyl of from one through three carbon atoms, alkylsulfonyl of from one through three carbon atoms, arylsulfonyl of from six through ten carbon atoms, alkylcarbamoyl wherein alkyl is from one through four carbon atoms, alkoxycarbonyl wherein alkyl is from one through four carbon atoms, ring monosubstituted aroylalkyl wherein the substituents have the same meaning as R, above, aryl is from six through ten carbon atoms and alkyl is from one through six carbon atoms and bis (ring monosubstituted) arylalkyl wherein the substituents have the same meaning as R, above, aryl is from six through ten carbon atoms and alkyl is from one through six carbon atoms; R.sup.1 and R.sup.2 when taken together with --N
    • 本发明涉及以下式所表示的新型4-苯基环己胺:其中差异是一般性表达式,其特征在于其独特的化学反应和其混合物及其混合物; R选自1至4个碳原子的烷基,1至4个碳原子的氟,氯,溴,三氟甲基,硝基和烷氧基; R'和R 1选自氢和一至四个碳原子的烷基; R2选自氢,一至四个碳原子的烷基,一至三个碳原子的烷酰基,一至三个碳原子的烷基磺酰基,六至十个碳原子的芳基磺酰基,其中烷基是 一个至四个碳原子,其中烷基是一个至四个碳原子的烷氧基羰基,其中取代基具有与上述R相同的含义的环单取代的芳酰基烷基,芳基是六至十个碳原子,烷基是一至六个碳原子 和双(环单取代)芳烷基,其中取代基具有与上述R相同的含义,芳基为6至10个碳原子,烷基为1至6个碳原子; R 1和R 2与-N'一起是选自未取代的和单取代的吡咯烷子基,哌啶子基,六亚甲基亚氨基,吗啉代和哌嗪基的饱和杂环氨基; 及其酸加成盐。 它还涉及制备上述新化合物(1)的中间体和方法及其新颖的衍生物。 新化合物(1)对人和动物的全身给药抑制其中枢神经系统。
    • 4. 发明授权
    • Benzospiran derivatives
    • Benzospiran衍生物
    • US3932425A
    • 1976-01-13
    • US460449
    • 1974-04-12
    • Daniel Lednicer
    • Daniel Lednicer
    • C07C13/72C07C49/675C07C49/683C07C49/697C07C49/747C07C49/755C07C57/50C07C59/54C07C59/86C07C205/45C07D295/02C07D295/033C07D295/096C07D295/135C07D317/22C07D319/08
    • C07D319/08C07C205/45C07C247/00C07C45/44C07C49/675C07C49/683C07C49/697C07C49/747C07C49/755C07C57/50C07C59/54C07C59/86C07D295/033C07D295/096C07D295/135C07D317/22C07C2103/94
    • This invention relates to novel benzospiran derivatives embraced by the formula ##SPC1##Wherein the sum of A and B is at least the integer 2; A is selected from the group consisting of --(CH.sub.2).sub.n -- wherein n is 1 through 5 and --(C.sub.n H.sub.2n --.sub.2 XY)-- wherein X is selected from the group consisting of hydroxy, acetoxy, amino and acetamido and Y is hydrogen, and X when taken together with Y is selected from the group consisting of =O and =CR.sup.3 R.sup.4 wherein R.sup.3 and R.sup.4 are selected from the group consisting of hydrogen and lower alkyl of 1 through 3 carbon atoms; B is absent or --(CH.sub.2).sub.n -- wherein n is 1 through 3; R.sup.1 is selected from the group consisting of hydrogen and lower alkyl of 1 through 3 carbon atoms; R.sup.2 is selected from the group consisting of hydrogen, lower alkyl of 1 through 3 carbon atoms, ##EQU1## WHEREIN N IS 2 THROUGH 5 AND Ar is phenyl having zero through three substituents selected from the group consisting of lower alkyl of 1 through 3 carbon atoms, lower alkoxy of 1 through 3 carbon atoms, bromine, chlorine and fluorine; R.sup.1 and R.sup.2 taken together with --N
    • 本发明涉及以下式所示的新型苯并环丙兰衍生物:其中A和B的至少为整数2; A选自 - (CH 2)n - ,其中n为1至5和 - (C n H 2n-2 XY) - 其中X选自羟基,乙酰氧基,氨基和乙酰氨基,Y为氢,以及 X与Y一起选自= O和= CR 3 R 4,其中R 3和R 4选自氢和1至3个碳原子的低级烷基; B不存在或 - (CH 2)n - ,其中n为1至3; R1选自氢和1至3个碳原子的低级烷基; R 2选自氢,1至3个碳原子的低级烷基,O和 - (CH 2)n CAr,其中N为2,并且Ar为具有0至3个选自下列基团的低级烷基的苯基: 1至3个碳原子,1至3个碳原子的低级烷氧基,溴,氯和氟; R 1和R 2与-N'一起是选自未取代的和取代的吡咯烷子基,哌啶子基和六亚甲基亚氨基的饱和杂环氨基; Z选自氢,1至3个碳原子的低级烷基,1至3个碳原子的低级烷氧基,1至3个碳原子的硝基,氨基,一烷基氨基,1至4个碳原子的酰基酰胺基,溴, 氯和氟; 及其药理学上可接受的酸加成盐。 它还涉及制备上述新化合物(1)的中间体和方法及其新颖的衍生物。 新化合物(1)对人和动物的施用抑制其中枢神经系统并降低其血压。
    • 6. 发明授权
    • Analgetic compounds, compositions and process of treatment
    • US4447454A
    • 1984-05-08
    • US263840
    • 1981-05-15
    • Daniel Lednicer
    • Daniel Lednicer
    • A61K31/135C07D295/135C07D317/72C07C87/34
    • C07D295/135C07C255/00C07D317/72
    • Novel compounds of the formula: ##STR1## wherein R.sub.1 is a variable consisting of hydrogen, alkyl of from 1 to 8 carbon atoms, CH.sub.2 -alkenyl wherein alkenyl is from 2 to 4 carbon atoms, inclusive, cycloalkyl of from 3 to 6 carbon atoms, inclusive, cycloalkylmethyl of from 3 to 6 carbon atoms, inclusive; R.sub.2 is a variable consisting of hydrogen, alkyl of from 1 to 8 carbon atoms, inclusive, with the proviso that R.sub.1 and R.sub.2 cannot both be hydrogen at the same time; Y is a variable consisting of alkyl of from 1 to 4 carbon atoms, inclusive, halogen, trifluoromethyl, hydroxy, alkanoyloxy from 2 to 5 carbon atoms, inclusive, alkoxy of from 1 to 4 carbon atoms, inclusive, cycloalkyloxy of from 3 to 6 carbon atoms, inclusive, benzyloxy; m is an integer 0, 1, 2; R.sub.5 is a variable consisting of hydrogen and alkyl of from 1 to 4 carbon atoms, inclusive; R.sub.3 is a variable consisting of alkyl of from 1 to 4 carbon atoms, inclusive; R.sub.4 is a variable consisting of alkyl of from 1 to 4 carbon atoms, inclusive, CH.sub.2 -alkenyl wherein alkenyl is of from 2 to 4 carbon atoms, inclusive, and arylalkyl wherein alkyl is from 1 to 4 carbon atoms, inclusive, and aryl is ##STR2## wherein Y' is CF.sub.3, halogen, alkyl of 1 to 4 carbon atoms, inclusive, and alkoxy of from 1 to 4 carbon atoms, inclusive; and R.sub.3 and R.sub.4 when taken together with the nitrogen atom to which they are attached can form saturated heterocycles of from 5 to 7 ring members, a second hetero atom of said ring can be oxygen or nitrogen, e.g., morpholine, piperazine, and said heterocycles can be monosubstituted having a total of up to 9 carbon atoms, with the proviso that when ##STR3## is pyrrolidinyl, then m=1, 2, having analgetic activity in humans and animals are prepared in unit dosage forms. The compositions are useful in relieving pain by administering orally, parenterally, and rectally to humans and animals.
    • 8. 发明授权
    • Analgetic compounds, compositions and process of treatment
    • 化学化合物,组合物和处理方法
    • US4113866A
    • 1978-09-12
    • US783806
    • 1977-04-01
    • Daniel Lednicer
    • Daniel Lednicer
    • C07D295/12C07D295/135C07D317/72A61K31/535
    • C07D295/135C07C255/00C07D317/72
    • Novel compounds of the formula: ##STR1## wherein R.sub.1 is a variable consisting of hydrogen, alkyl of from 1 to 8 carbon atoms, CH.sub.2 -alkenyl wherein alkenyl is from 2 to 4 carbon atoms, inclusive, cycloalkyl of from 3 to 6 carbon atoms, inclusive, cycloalkylmethyl of from 3 to 6 carbon atoms, inclusive; R.sub.2 is a variable consisting of hydrogen, alkyl of from 1 to 8 carbon atoms, inclusive, with the proviso that R.sub.1 and R.sub.2 cannot both be hydrogen at the same time; Y is a variable consisting of alkyl of from 1 to 4 carbon atoms, inclusive, halogen, trifluoromethyl, hydroxy, alkanoyloxy from 2 to 5 carbon atoms, inclusive, alkoxy of from 1 to 4 carbon atoms, inclusive, cycloalkyloxy of from 3 to 6 carbon atoms, inclusive, benzyloxy; m is an integer 0, 1, 2; R.sub.5 is a variable consisting of hydrogen and alkyl of from 1 to 4 carbon atoms, inclusive; R.sub.3 is a variable consisting of alkyl of from 1 to 4 carbon atoms, inclusive; R.sub.4 is a variable consisting of alkyl of from 1 to 4 carbon atoms, inclusive, CH.sub.2 -alkenyl wherein alkenyl is of from 2 to 4 carbon atoms, inclusive, and arylalkyl wherein alkyl is from 1 to 4 carbon atoms, inclusive, and aryl is ##STR2## WHEREIN Y' is CF.sub.3, halogen, alkyl of 1 to 4 carbon atoms, inclusive, and alkoxy of from 1 to 4 carbon atoms, inclusive; and R.sub.3 and R.sub.4 when taken together with the nitrogen atom to which they are attached can form saturated heterocycles of from 5 to 7 ring members, a second hetero atom of said ring can be oxygen or nitrogen, e.g., morpholine, piperazine, and said heterocycles can be monosubstituted having a total of up to 9 carbon atoms, with the proviso that when ##STR3## is pyrrolidinyl, then m = 1, 2, having analgetic activity in humans and animals are prepared in unit dosage forms. The compositions are useful in relieving pain by administering orally, parenterally, and rectally to humans and animals.
    • 10. 发明授权
    • 4'-Fluoro-4-{[4-(phenyl)-4-alkoxy-cyclo-hexyl]amino}butyrophenones and
the salts thereof
    • 4 {40-氟-4- {55 {8 4-(苯基)-4-烷氧基 - 环己基{9氨基{56丁基苯及其盐
    • US3965180A
    • 1976-06-22
    • US333896
    • 1973-02-20
    • Daniel Lednicer
    • Daniel Lednicer
    • C07C35/21C07C87/36
    • C07C35/21
    • This invention relates to novel 4-(substituted alkoxy)-4-(substituted phenyl)cyclohexylamines embraced by the formula ##SPC1##Wherein .about. is a generic expression denoting cis and trans stereoconfiguration and mixtures thereof, with the proviso that when the stereoconfiguration of the linkage connecting the cyclohexane ring and R.sup.3 O is is cis to the amino group, the linkage connecting the cyclohexane and phenyl rings is always trans, and vice versa; R is selected from the group consisting of lower alkyl of 1 through 4 carbon atoms, chlorine, fluorine, bromine, trifluoromethyl, and lower alkoxy of 1 through 4 carbon atoms; R' has the same meaning as R and in addition hydrogen; R.sup.1 is selected from the group consisting of hydrogen and lower alkyl of 1 through 4 carbon atoms; R.sup.2 is selected from the group consisting of hydrogen, lower alkyl of 1 through 4 carbon atoms, ring monosubstituted aroylalkyl wherein the substituents have the same meaning as R and R', above, aryl is from 6 through 10 carbon atoms and alkyl of from 1 through 4 carbon atoms and bis (ring monosubstituted)arylalkyl wherein the substituents have the same meaning as R and R', above, aryl is from 6 through 10 carbon atoms and alkyl of from 1 through 4 carbon atoms; R.sup.1 and R.sup.2 taken together with -N
    • 本发明涉及新颖的4-(取代的烷氧基)-4-(取代的苯基)环己基胺,其由下式表示:其中不同的是一般性表达式,其特征在于其独特的特征和混合物,以及当链接的连续化连接时 环己烷环和R 3 O与氨基是顺式的,连接环己烷和苯环的键总是反式的,反之亦然; R选自1至4个碳原子的低级烷基,氯,氟,溴,三氟甲基和1至4个碳原子的低级烷氧基; R'具有与R和氢相同的含义; R1选自氢和1至4个碳原子的低级烷基; R2选自氢,1至4个碳原子的低级烷基,环单取代的芳酰基烷基,其中取代基具有与R和R'相同的含义,上述芳基为6至10个碳原子,烷基为1 通过4个碳原子和双(环单取代)芳烷基,其中取代基具有与上述R和R'相同的含义,芳基为6至10个碳原子和1至4个碳原子的烷基; R 1和R 2与-N'一起是选自未取代的和单取代的吡咯烷子基,哌啶子基,六亚甲基亚氨基,吗啉代和哌嗪基的饱和杂环氨基; R3是1至4个碳原子的低级烷基; 及其酸加成盐。 它还涉及制备上述新化合物(1)的中间体和方法及其新颖的衍生物。 新化合物(1)对人和动物的全身给药抑制其中枢神经系统。